SectorMulti Cap

reliance pharma fund - direct (g)

3
Oro Rating
Long Term
Time Horizon
High
Risk level
Invest

Nippon India Pharma Fund Direct Plan Growth Plan Growth Option

1Year Returns2.45%
OutlookLong Term
Risk LevelHigh